Connective tissue diseases and psoriasis;Conectivopatías y psoriasis

Actas Dermo-Sifiliograficas

Volumn 102, Issue 7, 2011, Pages 487-497

  Cuesta Montero, L ^a   Belinchon I ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Dermatomyositis; Psoriasis; Rheumatoid arthritis; Scleroderma; Systemic lupus erythematosus

Indexed keywords

ARTICLE; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; DISEASE ASSOCIATION; HUMAN; MALE; PSORIASIS; RHEUMATOID ARTHRITIS; SYSTEMIC SCLEROSIS;

EID: 79961143755     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.ad.2011.03.002     Document Type: Short Survey

References (110)

1. a ed. Madrid: Médica Panamericana; 2004.
2. C. Ferrándiz, X. Bordas, V. García-Patos, S. Puig, R. Pujol, and A. Smandía Prevalence of psoriasis in Spain (Epiderma Project: Phase I) J Eur Acad Dermatol Venereol 15 2001 20 23 (Pubitemid 32842768)
3. E. Wielosz, M. Majdan, I. Zychowska, and R. Jeleniewicz Coexistence of five autoimmune diseases: diagnostic and therapeutic difficulties Rheumatol Int 28 2008 919 923
4. A. Ferahbas, S. Utas, O. Canoz, and C. Atavasun Coexistence of subacute cutaneous lupus erythematosus and psoriasis J Eur Acad Dermatol Venereol 18 2004 390 391 (Pubitemid 38618360)
5. Sociedad Española de Reumatología. Estudio EPISER: Prevalencia de las enfermedades reumáticas en la población española. España: Merck, Sharp & Dohme; 2001.
6. P. López, L. Mozo, C. Gutiérrez, and A. Suárez Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features Lupus 12 2003 860 865 (Pubitemid 37463106)
7. H. Vargas-Leguás, A. Selva-O'Callaghan, M. Campins-Martí, E. Hermosilla Pérez, J.M. Grau-Junyent, and X. Martínez Gómez Polymyositis-Dermatomyositis: incidence in Spain (1997-2004) Med Clin (Barc) 129 2007 721 724 (Pubitemid 350261372)
8. A. Villaverde-Hueso, M.P. De la Paz, M.C. Martín-Arribas, E. Sánchez-Valle, A. Ramírez-González, and P. Biairdi Prevalence of scleroderma in Spain: an approach for estimating rare disease prevalence using a disease model Pharmacoepidemiol Drug Saf 17 2008 1100 1107
9. J. Pedraz, E. Daudén, and I. Psoriasis Etiopatogenia, clínica y diagnóstico J. Conejo-Mir, J.C. Moreno, F. Camacho, Manual de Dermatología 2010 Aula Médica Madrid 171 184
10. a ed. Madrid: Editorial Médica Panamericana; 2009.
11. F.O. Nestle, D.H. Kaplan, and J. Barker Psoriasis N Engl J Med 36 2009 496 509
12. E.M. Farber, and M.L. Nall The natural history of psoriasis in 5,600 patients Dermatologica 148 1974 1 18
13. A.M. Bowcock, and J.G. Krueger Getting under the skin: the immunogenetics of psoriasis Nat Rev Immunol 5 2005 699 711 (Pubitemid 43090738)
14. R.C. Trembath, R.L. Clough, J.L. Rosbotham, A.B. Jones, R.D. Camp, and A. Frodsham Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis Hum Mol Genet 6 1997 813 820 (Pubitemid 27199077)
15. M.H. Allen, H. Ameen, C. Veal, J. Evans, V.S. Ramrakha-Jones, and A.M. Marsland The major psoriasis susceptibility locus PSORS1 is not a risk factor for late-onset psoriasis J Invest Dermatol 124 2005 103 106 (Pubitemid 40100955)
16. K. Asumalahti, M. Ameen, S. Suomela, E. Hagforsen, G. Michaëlsson, and J. Evans Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis J Invest Dermatol 120 2003 627 632 (Pubitemid 36344006)
17. M. Cargill, S.J. Schrodi, M. Chang, V.E. García, R. Brandon, and K.P. Callis A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes Am J Hum Genet 80 2007 273 290 (Pubitemid 46175676)
18. N. Wolf, M. Quaranta, N.J. Prescott, M. Allen, R. Smith, and A.D. Burden Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease J Med Genet 45 2008 114 116 (Pubitemid 351252875)
19. Y. Li, W. Liao, M. Chang, S.J. Schrodi, N. Bui, and J.J. Catanese Further genetic evidence for three psoriasis-risk genes: ADAM33, CDKAL1, and PTPN22 J Invest Dermatol 129 2009 629 634
20. A.B. Pernis Th 17 cells in rheumatoid arthritis and systemic lupus erythematosus J Intern Med 265 2009 644 652
21. L.A. Tesmer, S.K. Lundy, S. Sarkar, and D.A. Fox Th17 cells in human disease Immunol Rev 223 2008 87 113 (Pubitemid 351986173)
22. B. Afzali, G. Lombardi, R.I. Lechler, and G.M. Lord The role of T helper 17 (Th17) and regulatory cells (Treg) in human organ transplantation and autoimmune disease Clin Exp Immunol 148 2007 32 46 (Pubitemid 46365005)
23. A. Constanzo, M.S. Chimenti, E. Botti, R. Caruso, M. Sarra, and G. Monteleone IL-21 in the pathogenesis and treatment of skin diseases J Dermatol Sci 60 2010 61 66
24. E. Fitch, E. Harper, I. Skorcheva, S. Kurtz, and A. Blauvelt Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines Curr Rheumatol Rep 9 2007 461 467 (Pubitemid 350305203)
25. R. Caruso, E. Botti, M. Sarra, M. Esposito, C. Stolfi, and L. Diluvio Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis Nat Med 15 2009 1013 1015
26. G. Monteleone, F. Pallone, and T.T. Macdonald Interleukin-21: a critical regulator of the balance between effector and regulatory T-cell responses Trends Immunol 29 2008 290 294
27. L.A. Garrett-Sinha, S. John, and S. Gaffen IL-17 and the Th17 lineage in systemic lupus erythematosus Curr Opin Rheumatol 20 2008 519 525
28. E.A. Festen, P. Goyette, R. Scott, V. Annese, A. Zhernakova, and J. Lian Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis Gut 58 2009 799 804
29. S.J. Schrodi Genome-wide association scan in psoriasis: new insights into chronic inflammatory disease Expert Rev Clin Immunol 4 2008 565 571
30. K. Asano, H. Ikegami, T. Fujisawa, M. Nishino, K. Nojima, and Y. Kawabata Molecular scanning of interleukin-21 gene and genetic susceptibility to type 1 diabetes Hum Immunol 68 2007 384 391 (Pubitemid 46616978)
31. V.H. Teixeira, C. Pierlot, P. Migliorini, A. Balsa, R. Westhovens, and P. Barrera Testing for the association of the KIAA1109/Tenr/IL2/IL21 gene region with rheumatoid arthritis in a European family-based study Arthritis Res Ther 11 2009 R45
32. R. Chatterjee, J. Batra, and B. Ghosh A common exonic variant of interleukin 21 confers susceptibility to atopic asthma Int Arch Allergy Immunol 148 2009 137 146
33. B.W. Kirkham, M.N. Lassere, J.P. Edmonds, K.M. Juhasz, P.A. Bird, and C.S. Lee Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two year prospective study (the DAMAGE study cohort) Arthritis Rheum 54 2006 1122 1131 (Pubitemid 43672925)
34. X. Niu, D. He, X. Zhang, T. Yue, N. Li, and J.Z. Zhang IL-21 regulates Th17 cells in rheumatoid arthritis Hum Immunol 71 2010 334 341
35. D.A. Young, M. Hegen, H.L. Ma, M.J. Whitters, L.M. Albert, and L. Lowe Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis Arthritis Rheum 56 2007 1152 1163 (Pubitemid 46608640)
36. A.R. Moschen, S. Geiger, I. Krehan, A. Kaser, and H. Tilg Interferon-alpha controls IL-17 expression in vitro and in vivo Immunobiology 213 2008 779 787
37. M. Costner, and R. Grau Update on connective tissue diseases in dermatology Semin Cutan Med Surg 25 2006 207 220 (Pubitemid 44914058)
38. M. Lorber, M.E. Gershwin, and Y. Shoenfeld The coexistence of systemic lupus erythematosus with other autoimmune diseases: the kaleidoscope of autoimmunity Semin Arthritis Rheum 24 1994 105 113 (Pubitemid 24326548)
39. E. Baselga, L. Puig, J. Llobet, E. Musulén, and J.M. de Moragas Linear psoriasis associated with systemic lupus J Am Acad Dermatol 30 1994 130 133 (Pubitemid 24033832)
40. C.H. Hu, B.M. O'Connell, and E.M. Farber Coexistent psoriasis and lupus erythematosus: what's happening? Cutis 36 1985 449 450 (Pubitemid 16169782)
41. H.M. Johnson, J.K. Russell, and C.H. Pontzer Superantigens in human disease Sci Am 266 1992 42 48
42. P.A. O'Leary Chronic lupus disseminatus and psoriasis vulgaris Arch Dermatol Syphilol 15 1936 92
43. J.R. Millns, and S.A. Muller The coexistence of psoriasis and lupus erythematosus. An analysis of 27 cases Arch Dermatol 116 1980 658 663 (Pubitemid 10066848)
44. W.S. Lynch, and H.H. Roegnik Lupus erythematosus and psoriasis vulgaris Cutis 21 1978 511 525 (Pubitemid 8314117)
45. F. Ronglioletti, S. Casciaro, P. Boccaccio, and A. Rebora Annular pustular psoriasis and systemic lupus erythematosus Int J Dermatol 29 1990 290 292 (Pubitemid 20169393)
46. M.J. Zalla, and S.A. Muller The coexistence of psoriasis with lupus erythematosus and other photosensitive disorders Acta Derm Venereol 195 Suppl 1996 1 15 (Pubitemid 26099092)
47. a ed. 2006 Lippincott Williams and Wilkings Filadelfia
48. K. Kulick, H. Mogavero, T. Provost, and M. Reichlin Serologic studies in patients with lupus erythematosus and psoriasis J Am Acad Dermatol 8 1983 631 634 (Pubitemid 13129977)
49. S. Hays, C. Camisa, and M. Luzar The coexistence of systemic lupus erythematosus and psoriasis J Am Acad Dermatol 10 1984 619 622 (Pubitemid 14171234)
50. G.J. Kontochristopoulos, M. Giannadaki, G. Doulaveri, E. Christofidou, and N. Zakopoulou Psoriasis coexisting with subacute cutaneous lupus erythematosus J Eur Acad Dermatol Venereol 18 2004 385 386 (Pubitemid 38618356)
51. J. Callen Collagen vascular diseases J Am Acad Dermatol 51 2004 427 439
52. C. Berthelot, J. Nash, and M. Duvic Coexistent psoriasis and lupus erythematosus treated with alefacept Am J Clin Dermatol 8 2007 47 50 (Pubitemid 46998564)
53. E. Chlebus, H. Wolska, M. Blaszcyck, and S. Jablonska Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus. Diagnostic criteria and therapeutic implications J Am Acad Dermatol 38 1998 405 412 (Pubitemid 28125522)
54. A. Avriel, L. Zeller, D. Flusser, M. Shakra, S. Halevy, and S. Sukenik Coexistence of psoriatic arthritis and systemic lupus erythematosus Isr Med Assoc J 9 2007 48 49 (Pubitemid 46139848)
55. M.J. Dowdy, T.P. Nigra, and W.F. Barth Subacute cutaneous lupus erythematosus during PUVA therapy for psoriasis; case report and review of the literature Arthritis Rheum 32 1989 343 346 (Pubitemid 19100422)
56. L. Astudillo, L. Sailler, M. Carreiro, S. Dahan, S. Ollier, and P. Arlet Psoriasis and systemic lupus erythematosus: a rare association with specific therapeutic problems Ann Med Interne (Paris) 154 2003 3 6 (Pubitemid 36427905)
57. a ed. 2008 Mosby Elsevier España 115 135
58. R. Wolf, A. Lo Schiavo, M.L. Lomardi, F. De Angelis, and V. Ruocco The in vitro effect of hydroxychloroquine on skin morphology in psoriasis Int J Dermatol 38 1999 154 157 (Pubitemid 29136874)
59. S. Sorbara, E. Cozzani, A. Rebora, and A. Parodi Hydroxychloroquine in psoriasis: is it really harmful? Acta Derm Venereol 86 2006 450 451
60. L. Puig, X. Bordas, J.M. Carrascosa, E. Daudén, C. Ferrándiz, and J.M. Hernanz Consensus document on the evaluation and treatment of moderate-to-severe psoriasis. Spanish psoriasis group of the Spanish Academy of Dermatology and Venereology Actas Dermosifiliogr 100 2009 277 286
61. J.M. Weinberg An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis Clin Ther 25 2003 2487 2505 (Pubitemid 37373927)
62. V.J. Swalw, C.M. Perrett, C.P. Denton, C.M. Black, and M.H. Rustin Etanercept-induced systemic lupus erythematosus Clin Exp Dermatol 28 2003 604 607 (Pubitemid 37430879)
63. M.J. Kang, Y.H. Lee, and J. Lee Etanercept-induced systemic lupus erythematosus in a patient with rheumatoid arthritis J Korean Med Sci 21 2006 649 946
64. C.M. Vabre-Latre, P. Bayle, M.C. Marguery, A. Gadroy, D. Durand, and J. Bazex Worsening of subacute lupus erythematosus induced by infliximab Ann Dermatol Venereol 132 2005 349 353 (Pubitemid 40675715)
65. E. Williams, S. Gadola, and C.J. Edwards Anti-TNF-induced lupus Rheumatology 48 2009 716 720
66. M. De Bandt, J. Sibilia, X. Le Löet, S. Prouzeau, B. Fautrel, and C. Marcelli Systemic lupus erythematosus induced by anti-tumor necrosis factor alpha therapy: a French national survey Arthritis Res Ther 2 2005 R545 551
67. H.W. Walling, and R.D. Sontheimer Cutaneous lupus erythematosus: issues in diagnosis and treatment Am J Clin Dermatol 10 2009 365 381
68. A. Menter, N.J. Korman, C.A. Elmets, S.R. Feldman, J.M. Gelfand, and K.B. Gordon Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents J Am Acad Dermatol 61 2009 451 485
69. J.T. Gran, R. Gunnarsson, and N.J. Mork A man with erythrodermia, muscle weakness and weight loss Tidsskr Nor Laegeforen 129 2009 2240 2241
70. M.D. Pavlovic, R.D. Zecevic, and L. Zolotarevski Psoriasis in a patient with dermatomyositis Vojnosanit Pregl 61 2004 557 559
71. P. Gerami, J.M. Schope, L. McDonald, H.W. Walling, and D. Sontheimer A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies J Am Acad Dermatol 54 2006 597 613
72. J.S. Kasteler, and J.P. Callen Scalp involvement in dermatomyositis. Often overlooked or misdiagnosed JAMA 28 1994 1939 1941
73. M. Haroon, and J. Devlin Gottrons's papule in amyopathic dermatomyositis mimicking psoriasis Clin Rheumatol 28 2009 1245 1246
74. A.M. Layton, R.A. Sheehan-Dare, M.J.D. Goodfield, and J.A. Cotterill Hydroxyurea in the management of therapy resistant psoriasis Br J Dermatol 121 1989 647 653 (Pubitemid 19275253)
75. S. Varma, and S.W. Lanigan Dermatomyositis-like eruption and leg ulceration caused by hydroxyurea in a patient with psoriasis Clin Exp Dermatol 24 1998 164 166
76. P.A. Sinoway, C.L. Davidson, and J.P. Callen Dermatomyositis occurring during psoralen A (PUVA) J Rheumatol 21 1994 353 356
77. S. Ochi, T. Nanki, K. Takada, F. Suzuki, Y. Komano, and T. Kubota Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis/dermatomyositis Clin Exp Rheumatol 23 2005 707 710 (Pubitemid 41300719)
78. J.C. Edge, J.D. Outland, J.R. Dempsey, and J.P. Callen Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis Arch Dermatol 142 2006 65 69 (Pubitemid 43107363)
79. G.J. Hengstman, F.H. Van den Hoogen, P. Barrera, M.G. Netea, A. Pieterse, and L.B. van de Putte Successful treatment of dermatomyositis and polymyositis with anti-tumor necrosis factor alpha: preliminary observations Eur Neurol 50 2003 10 15 (Pubitemid 36736963)
80. K.A. Qushmaq, A. Chalmers, and J.M. Esdaile Cyclosporin A in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review J Rheumatol 27 2000 2855 2859
81. J. Wenzel, and T. Bieber Cyclosporin A in treatment of refractory adult polymyositis/dermatomyositis J Rheumatol 28 2001 2139 (Pubitemid 32803799)
82. F.P. Hurst, R.T. Neff, R.M. Jindal, J.R. Roberts, K.L. Lentine, and L.Y. Agodoa Incidence, predictors and associated outcomes of rhabdomyolysis after kidney transplantation Nephrol Dial Transplant 24 2009 3861 3862
83. R. Valero, E. Rodrigo, Zubimendi, and M. Arias Rabdomiólisis secundaria a interacción de estatinas con macrólidos en un paciente con trasplante renal Nefrología 4 2004 382 383 (Pubitemid 39242655)
84. L.S. Sauter Systemic scleroderma (progressive systemic sclerosis), chemical diabetes mellitus, psoriasis Arch Dermatol 103 1971 682 685
85. N.G. Korotkii, G.I. Sharanova, V. Udzhukhu, N.A. Antonova, and M.A. Panchenko A case of severe form of psoriasis and systemic scleroderma Vestn Dermatol Venerol 5 1984 48 49
86. I.V. Khamaganova Association of scleroderma and psoriasis Vestn Dermatol Venerol 6 1986 66 68
87. T. Yamamoto, I. Katayama, and K. Nishioka A rare association of systemic sclerosis with psoriasis vulgaris J Dermatol 27 2000 346 349 (Pubitemid 30431752)
88. B. Harrison, A. Herrick, and C. Griffiths Psoriasis and diffuse systemic sclerosis: a report of three patients Rheumatology (Oxford) 39 2000 213 215 (Pubitemid 30139360)
89. R.D. Armstrong, and T. Gibson Scleroderma and erosive polyarthritis: a disease entity? Ann Rheum Dis 41 1982 141 146 (Pubitemid 12158515)
90. G. Valentini, G. Belfiore, L. Celentano, D.A. Moles, G. la Montagna, and A. Sodano La sacroileite sclerodermica. Una entita anatomo-radiologica non nota Reumatismo 42 1990 117 126
91. C. Girolamo, C. Rengo, M.G. Ferrucci, E. Miniero, G. Cuomo, and C. Crisci Systemic sclerosis could mask the presentation of psoriasis in a patient with symptomatic and bilateral sacroiliitis Scand J Rheumatol 32 2003 186 188 (Pubitemid 36819387)
92. A.N. Sapadin, and R. Fleischmajer Treatment of scleroderma Arch Dermatol 138 2002 99 105 (Pubitemid 34056240)
93. A.D. Cohen, M. Kagen, M. Friger, and S. Halevy Calcium channel blockers intake and psoriasis: a case-control study Acta Derm Venereol 81 2001 347 349 (Pubitemid 34015490)
94. K. Kitamura, M. Kanasashi, C. Suga, S. Saito, S. Yoshida, and Z. Ikezawa Cutaneous reactions induced by calcium cannel blocker: high frequency of psoriasiform eruptions J Dermatol 20 1993 279 286 (Pubitemid 23205539)
95. C. Marquart-Elbaz, E. Grosshans, D. Lipsker, and D. Lipsker Sartans, angiotensin II receptor antagonists, can induce psoriasis Br J Dermatol 147 2002 617 618 (Pubitemid 35015313)
96. G. Lamba, C. Palaniswamy, T. Singh, D. Shah, S. Lal, and R. Vinnakota Psoriasis induced by losartan therapy: a case report and review of the literature Am J Ther 2009 19
97. J.H. Korn, M. Mayes, M. Matucci, M. Rainisio, J. Pope, and E. Hachulla Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist Arthritis Rheum 50 2004 3985 3993 (Pubitemid 39643947)
98. B. Lewandowski, I. Domyslawsaka, P.A. Klimiuk, and S. Sierakowski Kidney crisis in systemic sclerosis Rocz Akad Med Bialymst 50 2005 294 296
99. F. Rongioletti, C. Fiorucci, and A. Parodi Psoriasis induced or aggravated by drugs J Rheumatol Suppl 83 2009 59 61
100. R. Wolf, and V. Ruocco Triggered psoriasis Adv Exp Med Biol 455 1999 221 225 (Pubitemid 32187464)
101. R. Mazzucchelli, M. Yebra, C. Barbadillo, E. Berrocal, J.C. Gea, and J.L. Andreu-Sánchez Double disease in rheumatology: coexistence of rheumatoid arthritis and psoriatic arthritis Clin Exp Rheumatol 10 1992 83 85
102. S. Kary, M. Worm, H. Audring, D. Huscher, M. Renelt, and H. Sörensen New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists Ann Rheum Dis 65 2006 405 407 (Pubitemid 43268235)
103. T. Yamamoto Coexistence of bullous rheumatoid neutrophilic dermatosis and palmoplantar pustulosis in a patient with rheumatoid arthritis Int J Dermatol 49 2010 334 348
104. L. Kwan-Hoon, S. Myoung-Kun, H. You-Jung, C. Sang-Tae, L. Sang-Won, and P. Yong-Beom Inflammatory polyarthritis in a patient with psoriasis: is it psoriatic arthritis or rheumatoid arthritis? Korean J Intern Med 25 2010 224 226
105. N. Bizzaro Antibodies to citrullinated peptides: a significant step forward in the early diagnosis of rheumatoid arthritis Clin Chem Lab Med 45 2007 150 157 (Pubitemid 46294678)
106. G.M. Alenius, E. Berglin, and S. Rantapaa Dahlqvist Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation Ann Rheum Dis 65 2006 398 400 (Pubitemid 43268233)
107. A. López-Ferrer, V. Torrente-Segarra, and L. Puig Psoriatic arthritis: what the dermatologist needs to know, part 1 Actas Dermosifiliogr 101 2010 578 584
108. W. Taylor, D. Gladman, P. Helliwell, A. Marchesoni, P. Mease, H. Mielants CASPAR study group Classification criteria for psoriatic arthritis: development of new criteria from a large international study Arthritis Rheum 54 2006 2665 2673 (Pubitemid 44205029)
109. P.P. Sfikakis, A. Iliopoulos, and A. Elezoglou Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction Arthritis Rheum 52 2005 2513 2518 (Pubitemid 41117439)
110. M. Flendrie, W.H. Vissers, M.C. Creemers, E.M. De Jong, P.C. Van der Kerkhof, and P.L. Van Riel Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study Arthritis Res Ther 7 2005 R666 R676